Novus Acquisition (NDEV) Partners with Enlighten Interactive TV to Bring its Cannabis MedPlan to the Masses

Novus Partners with Enlighten Interactive TV to Bring its Cannabis MedPlan to the Masses

Novus Acquisition and Development Corp. (OTC PINK: NDEV), through its wholly owned subsidiary WCIG Insurance Services, Inc., is a diversified insurance entity in health, liability, annuity and accident, and the nation’s first carrier/aggregator offering a cannabis health plan, today announced its business collaboration recently announced is with Enlighten, a multifaceted cannabis technology company.

Novus will utilize Enlighten’s interactive television technologies in a revenue sharing deal. Enlighten will place Novus’ message at the point of sales in 650 dispensaries across the country with advertising to engage and educate consumers on the Novus Cannabis MedPlan. When consumers are engaged Novus will get analytics of verified impressions from the consumer mobile devices for retargeting.

Enlighten’s technology solutions include interactive signage to inform and educate customers or employees, a retail analytics portal, integrated technology solutions to aggregate and systemize product offerings and internal operations, and tailored marketing solutions for product brands.

The company’s engagement focused approach helps its location partners match the look and feel of modern technology-driven facilities, while maintaining a unique identity, to educate its target audience and increase revenue. Enlighten offers brands across the country with the unique ability to reach a targeted demographic with engaging advertisement right at the point of sale.

Novus’ Chief Executive Officer, Frank Labrozzi, commented, ”We are thrilled to be working with the team at Enlighten as they have built out the first full scale interactive enterprise solution in the cannabis space. Enlighten is already working with over 650 cannabis businesses, including dispensaries, cultivators, cannabis lounges and medical facilities. We believe our revolutionary medical cannabis health plan will greatly benefit in becoming part of Enlighten’s network. We continue to seek additional ways to increase our consumer visibility and awareness in bringing reliable and affordable meds to consumers around the nation.”

Continue reading
  1 Hits
  0 Comments
1 Hits
0 Comments

Namaste Technologies Inc. (NXTTF) announces achieving over 6,000 registered NamasteMD users ahead of July 1 target

Namaste announces achieving over 6,000 registered NamasteMD users ahead of July 1 target and launches new marketing initiatives

Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N.V)(M5BQ.F)(NXTTF) is pleased to announce that the Company has exceeded its July 1 st goal and has acquired over 6,000 registered users on NamasteMD with a 4.9-star rating based on 209 reviews on Apple iOS devices and a 4.7-star rating on Google Android based on 106 consumer reviews. These results have exceeded the Company’s July 1 target of 5,000 registered users and Namaste anticipates further acceleration of its database during the second half of the year with new marketing initiatives and strategic partnerships including applications of NamasteMD for Indigenous communities, targeted healthcare organizations, digital marketing and high-traffic content networks.

NamasteMD is Canada’s first fully-integrated medical cannabis telemedicine application available on iPhone and Android devices, which provides free consultations in an enhanced online environment. Namaste’s ability to acquire medical cannabis patients online, with an acquisition cost of only $59.00 per patient, will propel NamasteMD to become Canada’s largest database of Canadian medical cannabis patients.

Namaste is now focused on launching a comprehensive marketing strategy that will include content networks, digital marketing and PPC advertising. NamasteMD will provide remote access to rural communities which suffer from little access to healthcare services. The Company will leverage its technology in partnerships with rural Indigenous communities as well as specialized healthcare groups to further accelerate patient growth over the next six months.

Namaste is confident that it will achieve its goal of acquiring 50,000 patients in 2018, with a target of 200,000 in 2019. Namaste has firmly established itself as a global innovator of technology platforms, e-commerce, telemedicine and artificial intelligence, all of which provide significant value to Namaste’s growing revenue and in creating innovation within the cannabis industry.

Management Commentary

Continue reading
  1 Hits
  0 Comments
1 Hits
0 Comments

Future Farm Technologies Inc. (FFRMF) Announces Issuance of Interim Order and Provides Updates for NexTech Spin-Out

Future Farm Announces Issuance of Interim Order and Provides Updates for NexTech Spin-Out

Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQX: FFRMF) is pleased to announce that on June 21 the Supreme Court of British Columbia issued the Interim Order permitting Future Farm to conduct an annual general and special meeting of its shareholders at 10:00 a.m. (Vancouver time) on Thursday, July 26, 2018 at 1200 – 750 West Pender Street, Vancouver, British Columbia. At the meeting the shareholders will, amongst other things, consider and, if deemed advisable, pass, with or without amendment, a special resolution authorizing a plan of arrangement among Future Farm, the Future Farm shareholders and NexTech AR Solutions Corp. (“NexTech”).

If the plan of arrangement is approved, Future Farm will, effectively, spin-out 11,000,000 common shares of NexTech now owned by Future Farm to the Future Farm shareholders on a pro rata basis. Future Farm shareholders will then own approximately 25.86% of the issued and outstanding common shares of NexTech. On a per share basis, Future Farm shareholders would be entitled to receive, for every one common share of Future Farm held by them, a fraction of a NexTech common share equal to the quotient of 11,000,000 NexTech common shares divided by the number of Future Farm common shares outstanding on the close of business on the last trading day on the CSE immediately prior to the effective date (the “Effective Date”) of the plan of arrangement. For example, based on the 125,577,358 Future Farm common shares issued and outstanding as of June 22, 2018, Future Farm shareholders would be entitled to receive, for every one Future Farm common share held, approximately 0.0876 of a NexTech common share. The actual ratio will be different because it is not possible at this time to know the exact number of Future Farm shares that will be outstanding on the last trading day before the Effective Date.

The last trading day on the CSE immediately prior to the Effective Date will also be the record date for the distribution of NexTech shares (the “Share Distribution Record Date”). In other words, any Future Farm shareholder of record on the Share Distribution Record Date will be the shareholder who receives the NexTech shares to be spun out. The Share Distribution Record Date cannot be set until the plan of arrangement is approved by the Future Farm shareholders at the meeting, the British Columbia Supreme Court issues its final order approving the arrangement and other customary closing conditions are met. Future Farm expects that process will result in the Share Distribution Record Date being August 7. Notice of the actual Share Distribution Record Date and the Effective Date will be given to the Future Farm Shareholders through one or more press releases.

Future Farm expects to mail a Management Information Circular regarding the plan of arrangement this week. The Management Information Circular contains important detailed information which should be reviewed carefully by all Future Farm shareholders before they determine how to vote their shares.

The securities referenced in this news release have not and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Continue reading
  1 Hits
  0 Comments
1 Hits
0 Comments

Marijuana Stocks to Look Out for This Year

The industry on cannabis in North America has managed to remain incredibly lucrative over the course of the past five years. With so many new legal moves being put in place, it seems as though the future of the industry is headed in the positive direction.

Debra Borchardt, the CEO of the Green Market Report stated that in regard to the new legalization of recreational cannabis in Canada, “October 17th was set as the first day for recreational sales. Some people in the industry wanted an earlier date, but at least companies can now make plans for a specific date.” This move by Canada has also helped to involve some of the large markets abroad. Many companies in Canada have been working to cement partnerships and acquisitions in foreign markets such as Germany and Jamaica. These partnerships are still some way down the line, but they do present a very positive case for the future of the industry.

Jeff Siegel, managing editor of Green Chip Stocks stated that some stocks “are gong to continue to see a flood of capital coming in… much of which was previously flooding into Canada.” Borchardt continued to state as well that “the other big news was that Tilray filed for an IPO on the NASDAQ. The company reported solid financial numbers, and that will make this a sought-after offering among cannabis investors. Tilray will be a ‘controlled company’ since Privateer Holdings will have the majority voting power.”

In other news, the popular marijuana magazine High Times is now working to crowdfund a campaign that would allow them to go public on the NASDAQ later in the year. The company stated recently that “the company is only weeks away from publicly listing on the NASDAQ, just weeks after organizing America’s first state-sanctioned recreational cannabis event in Sacramento. This is an enormous opportunity for the general populous to buy into the growing green rush, and they’re just getting started.” This hopeful sentiment is very much shared across the board and continues to be the driving factor for growth in the industry and abroad.

The U.S. Marijuana Index did, however, drop by a small amount of around 3% earlier in the week, but this has been attributed to some anxiety surrounding the legalization of recreational cannabis in Canada. Other stocks on the individual level such as certain ETFs managed to grow above 5%, showing a very hopeful sentiment for the future.

Continue reading
  1 Hits
  0 Comments
1 Hits
0 Comments

Marijuana Stocks Newsletter – Happy Monday June 25, 2018

Good Morning & Happy Monday! – 6/25/2018!

What’s The Next Big Wave For MJ?With Canada’s recreational MJ industy recently being legalized, cannabis stocks are captivating the markets. And if you’ve been following along, you would have already seen that one particular MJ Stock could be making a new trend and we’ve got the details for you, here.Read The Full Report

Could Cannabis be Decriminalized in the Near Future?With all of the news coming out regarding the legalization of cannabis throughout Canada, many are wondering if the U.S. will be the next state to make marijuana nationally legal.Read The Full Article Here

UPDATE: What Does Canada’s Legalization Mean For Pot Stocks?Unless you’ve been living under a rock, you know that the cannabis industry has been heating up for the last four years. A big move being made but our neighbors to the north could give investors one of the biggest calls to action with Canadian marijuana stocks taking center stage.Read The Full Article Here

Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of MAPH Enterprises, LLC owner of MarijuanaStocks.com and Leafbuyer Technologies, Inc, we were hired for a period from 2/2/2018 – 5/2/2018 to publicly disseminate information about (LBUY) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for & were paid “77,000” shares of restricted common shares. We own zero shares of (LBUY), which we purchased in the open market. Once the (6) Six month restriction is complete on 8/2/2018 we plan to sell the “77,000” shares of (LBUY) that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and Beleave Inc., Midam has been paid $200,000 from the company and ZERO shares of Beleave Inc. for a duration of 6 weeks beginning June 18, 2018 and ending July 31, 2018. We may buy or sell additional shares of (BLEVF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Continue reading
  1 Hits
  0 Comments
1 Hits
0 Comments

GB Sciences, Inc. (GBLX) Files Patents for Heart Disease and Chronic, Immunological, and Neuropathic Pain

GB Sciences Files Patents for Heart Disease and Chronic, Immunological, and Neuropathic PainGB Sciences, Inc. (GBLX) has filed nonprovisional patent applications to protect its myrcene-containing complex mixtures (“MCCC”) for the treatment of chronic pain and heart disorders. These new US and PCT international applications claim the benefit of GB Sciences’ provisional application previously filed on May 22nd, 2017, supplying additional data from patch-clamp studies on individual cells that further support their claims. Novel pain treatments are a promising field of research and development given concerns regarding opioid usage and potential for abuse. The Company’s novel pain formulations are also substantially free of delta-9 tetrahydrocannabinol (“THC”), which minimizes their potential for abuse. Pain represents an estimated health burden of between $560 and 650 billion dollars for chronic pain and between $17 and $20 billion dollars for immunological/neuropathic pain in the US alone. In addition, these novel cardiac formulations address the $316 billion-dollar cardiac therapy market in the US.

“GB Sciences’ myrcene-containing complex mixtures for heart disease and chronic pain leverage powerful molecular synergies between specific complex formulations of active ingredients derived from the cannabis plants including many terpenes and minor cannabinoids,” said Dr. Andrea Small-Howard, Chief Science Officer of GB Sciences, Inc. “Our formulations capture whole plant medicine’s benefits, but they are further optimized and standardized. In preclinical studies, these complex mixtures have a greater therapeutic potential than the sums of the therapeutic effects of the individual ingredients. Other companies are creating cannabis-based therapeutics primarily based on one or two major cannabinoids, but our data suggests that complex formulations targeting specific diseases containing as many as a dozen ingredients provide greater potential clinical benefits than single- or double-active ingredient formulas.”

The Company’s drug discovery efforts were accelerated through the powerful combination of GB Sciences’ proprietary in silico prediction approach, termed the GB Sciences’ Network Pharmacology Platform (“NPP”), and GB Sciences’ proven high-throughput screening techniques using cell-based models of pain and heart disease. The current nonprovisional patent application covers myrcene-containing complex mixtures that are capable of targeting the non-traditional cannabinoid receptor, TRPV1. The latest patent application complements the issued TRPV1 patent that GB Sciences licensed from Makai Biotechnology in December of 2016.

“GB Sciences is developing these pain and heart formulas in accordance with our strategy of commercializing complex mixtures of cannabis-derived compounds whose pharmaceutical activity does not require THC,” explains John Poss, Chairman and CEO of GB Sciences, Inc. “In addition, we are creating time-released forms of these formulations through our joint nanotech research program with the University of Seville. Our commitment to providing novel therapies and improved delivery methods will be tested in a pilot human trial in 2019.”

The post GB Sciences, Inc. (GBLX) Files Patents for Heart Disease and Chronic, Immunological, and Neuropathic Pain appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Original link
  1 Hits
  0 Comments
1 Hits
0 Comments

Could Cannabis be Decriminalized in the Near Future?

With all of the news coming out regarding the legalization of cannabis throughout Canada, many are wondering if the U.S. will be the next state to make marijuana nationally legal.

The Canadian parliament recently stated that they will be allowing via a bill known as C-45, the sale of cannabis throughout the nation for adult use. This is the first time that a G7 nation has made cannabis recreational legal nationwide, and continues to present a new path that the industry could take on. One of the senators who sponsored the bill, Tony Dean, stated recently that “I’m feeling just great. We’ve just witnessed a historic vote for Canada.” The Prime Minister of Canada, Justin Trudeau, also stated a similar sentiment stating that “today, we change that.” This is in regard to the new laws and takes into account the massive nature of this new bill. Since this is the first time that this is occurring, many are wondering where the U.S. will be on their policy in the near future and whether or not they can use Canada as an example to make new policies.

Paul Armentano, the deputy director of the National Organization for the Reform of Marijuana Laws, stated that “America’s leaders would be wise to learn from our neighbors, who are replacing their archaic and failed marijuana prohibition laws with a regulatory scheme that is largely evidence-based and that reflects cannabis’s rapidly changing cultural status.” For too long, the U.S. has been in a constant battle with state laws regarding whether or not cannabis should be legal. Not only has this halted the growth of the industry by a large amount, but the public conception of cannabis seems to be incredibly in favor of legalization which continues to beg the question of why the federal government will not change these old and failed laws.

The President of NORML’s Canada branch, John Conroy, stated that the decision for Canada to legalize cannabis “will undoubtedly have some bearing on how things will ultimately play out federally in the U.S.”

A new report has come out showing that as much as 62% of the U.S. is in favor of legalizing cannabis to some extent. Given that the number of those who support cannabis legislation is so high, it would make sense for the government to take this into consideration and make a change for the coming years. One of the main individuals who is in opposition of changing the laws is Attorney General Jeff Sessions. Sessions recently stated that he will continue to take his tough stance on the existing laws that enforce cannabis legislation in the U.S. Although this sentiment is quite in opposition to what the people want, the overwhelming majority of those in office have stated that they are in full support of having some form of cannabis reform in the near future.

Continue reading
  1 Hits
  0 Comments
1 Hits
0 Comments

Full vending machines. Pot on the pillow. What some California hotels are doing to attract marijuana smokers - Cannabis News

Like the rest of California, the hospitality industry in the state has moved slowly and tentatively to embrace the use of cannabis on a widespread basis.

 A few months after California legalized recreational use of marijuana, the Desert Hot Springs Inn in the Coachella Valley began advertising itself as cannabis friendly — a place where guests can smoke by the pool or heat up a vaporizer in the rooms.

What surprised innkeeper John Thatcher was not only that business improved by as much as 50% but that most of his pot-smoking guests were upper-income baby boomers.

Click here to read the complete article

Hugo Martin ~ LATimes.com ~ 

Original link
  10 Hits
  0 Comments
10 Hits
0 Comments

Northern California’s Cannabis Community Is Picking Up The Pieces Six Months After The Wildfires - Cannabis News

When the wildfires ripped across California in October 2017, it was devastating for all industries, but the cannabis community was hit especially hard.

At 1:30 a.m. on October 8th, Jennifer Michaels was awake in bed in her Sonoma County home.

She had two important meetings the next day, and while she noticed the fire out the window, she was mostly thinking about the cannabis seed company in Las Vegas she was meeting with.

"I had no idea at the time what was even going on," she recounted six months after a devastating fire swept through the Sonoma Valley. 

Click here to read the complete article

Continue reading
  10 Hits
  0 Comments
10 Hits
0 Comments

The Green Organic Dutchman Holdings Ltd. (TGOD) Announces Additional 40,000 kg of Production Dedicated to Beverage and Edible Product Manufacturing

The Green Organic Dutchman Announces Additional 40,000 kg of Production Dedicated to Beverage and Edible Product ManufacturingThe Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TGOD.TO) (TGODF) is pleased to announce that it has decided to add a 287,245 sq ft. purpose-built facility on its Valleyfield property capable of producing 40,000 kgs of premium organic cannabis. This facility will be dedicated to TGOD’s Beverage Division and increases the Company’s fully-funded capacity to 170,000 kgs.

This newly dedicated cultivation building is being constructed to support TGOD’s previously announced Beverage Division Global-Strategic-Launch-Into-the-Beverage-Industry. This includes a state-of-the-art manufacturing campus designed to conduct strain-specific studies, develop organic IP, and create consumable optimized CBD / THC strains. Due to operating efficiencies within the 72.4 acre Valleyfield property, permits and cultivation licenses granted, the Company anticipates a significantly reduced construction timeline and budget. The Company will build this facility using excess cash raised in its IPO and subsequent bought deal financings. With the synergies to be realized on the existing 72.4 acre Valleyfield property, the construction timeline and unit costs for this additional building enhance the overall economics of the entire facility.

TGOD’s Beverage Division team has a unique understanding of the strict disciplines required for the large-scale, lean-manufacturing of base ingredients used in a multitude of higher margin products. The process begins with TGOD’s breeding facility, moves to the purpose-built cultivation, followed by the state-of-the-art 40,000 sq. ft. Innovation Centre.  TGOD’s beverage production facility will fill the market’s current void and supply premium organic cannabis for R&D specific development in products such as edibles and beverages.

“With the legalization of cannabis announced on June 20th, and Premier Justin Trudeau setting the legalization date of October 17th, the path is paved. The time is now to dedicate infrastructure, services and expertise to developing proprietary products. This is just another step for TGOD in its business plan of creating a distribution hub for large-scale beverage and edible products which can be introduced in Canada and internationally,” said Csaba Reider, TGOD’s President.

“We believe that the beverage and edible market will be the largest single segment of the cannabis market. Cannabis, as the base ingredient, makes these products possible. The medicinal and recreational market for CBD and THC will only increase over time and starting with an organic input is the most important aspect to developing these higher margin products,” continued Mr. Reider.

This facility is fully funded and provides TGOD with a combined funded capacity of 170,000 kgs across four facilities in two countries.

Continue reading
  11 Hits
  0 Comments
11 Hits
0 Comments

Beleave Inc. (BLEVF) Applauds Canadian Leadership and Continued Progress of Cannabis Legalization

Beleave Applauds Canadian Leadership and Continued Progress of Cannabis Legalization

Beleave Inc. (CSE: BE) (OTCQX: BLEVF) (“Beleave” or the “Company“) would like to commend the outstanding leadership, tenacity, and bravery of the Canadian government in passing Bill C-45 into law. As the first G7 country to legalize cannabis, this forever reaffirms Canada’s reputation as a forward-thinking nation to live and do business in.

Beleave continues to build its distribution to be well-positioned to meet the demand of the recreational and medical cannabis markets.  The Company’s greenhouse expansion in Hamilton is well underway while it is continuing to expand its network of medical clinics by way of the Medi-Green brand and its recreational retail stores through a newly-granted retail license in Saskatchewan.  The Saskatchewan license is the first of many proposed retail locations the Company plans to roll out in Canada which will offer a diverse range of products available both online and in store.

“Beleave has had a great year so far,” said Beleave’s CEO, Andrew Wnek . “This milestone has been a long-time coming and now that it’s here we can celebrate another win and move forward. We feel the comprehensive regulatory framework for adult cannabis use is fair and will work to eliminate the black market, protect our youth, and remain mindful of public health and safety.”

The Company released news yesterday announcing its global expansion into Colombia , a jurisdiction believed to be right behind Canada on the path to legalized and regulated cannabis. The Company plans to strike more deals in a well thought out and strategic manner advantageous to shareholder growth without paying the high premiums currently associated with todays cannabis marketplace.

“We’ve raised roughly $20 million in the last several months, strengthening the company’s balance sheet to capitalize on industry opportunities. We thank our investors for their continued confidence and support,” commented Bojan Krasic , Beleave’s Director and CFO. “Also, we acknowledge the diligence of our amazing team. Their hard work, dedication, and innovation has prepared us like never before for this next chapter in Beleave’s story.”

Continue reading
  10 Hits
  0 Comments
10 Hits
0 Comments

Cannabis Growth in Canada is Kicking Up a Notch

There’s no doubt that the Canadian market on cannabis has been leading the rest of the world in terms of growth and innovation, but new companies are beginning to outdo even the high standards that are currently in place.

The adult-use weed market in Canada has the potential to generate as much as $5 billion in annual sales. This is quite a large amount considering where the industry currently stands and how much it could grow in the coming years. Many growers have begun to up their production to attempt to meet this high and new demand, but there seems to be an increasing amount of competition to fill the gap. Many big companies in the growing side of the industry in Canada have been buying up new factories to begin this massive growth effort, but the hopes are that there will not be an overproduction in the future as that could curb sales and lower prices.

Many companies have come to light because of this new industry such as the Green Organic Dutchman (NASDAQOTH:TGODF). The company recently announced a new partnership that could potentially make them one of the top four growers of cannabis in all of Canada.

The company MedReleaf is another one of the large Canadian growers of cannabis and is expected to grow as much as 140,000 kg of cannabis in the coming year. The company has stated that they are working to see if a partnership can be formed with Aurora Cannabis for an acquisition that would come in at around $2.5 billion in share prices. If this deal goes through, it would mean that Aurora could potentially be growing as much as 570,000 kg at their maximum output of cannabis production. This would effectively make them the largest grower of cannabis in North America, followed by Canopy Growth at around 500,000 kg and Aphria at around 250,000 kg. The Green Organic Dutchman would be producing around 130,000 kg per year, helping to cement their place at near the top of this list.

The company Organic Dutchman has stated that they will be partnering with one of the largest growing companies in Jamaica to begin construction on a new 125,000 sq. ft. production facility. This production would be combined with their new 820,000 square foot production space in Quebec Canada. The CEO of the company, Robert Anderson recently stated that “This represents the first of many strategic partnerships TGOD intends to execute in the coming months. Our value-added approach taken in this investment will set an international M&A framework for capital investment, transfer of knowledge, and sector expertise. We will continue to evaluate international opportunities that will assist us in executing our business plan to become the world’s largest cannabis brand.”

Continue reading
  7 Hits
  0 Comments
7 Hits
0 Comments

Marijuana Stocks Newsletter – Happy Friday June 22, 2018

Good Morning & Happy Friday! – 6/22/2018!

SPECIAL REPORT: What Does Canada’s Legalization Mean For Pot Stocks?Unless you’ve been living under a rock, you know that the cannabis industry has been heating up for the last four years. A big move being made but our neighbors to the north could give investors one of the biggest calls to action with Canadian marijuana stocks taking center stage.Read The Full Article Here

InCaseYouMissedIt: Beleave Inc. (BLEVF) Expands its Global Footprint into ColombiaBeleave Inc. (CSE: BE) (BLEVF) announcde it has acquired 51% of Procannmed S.A.S. (“Procannmed“), a privately held company that is fully licensed for the cultivation, production, extraction and distribution of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis in Colombia. The other 49% ownership was retained by the Colombian based operator ITRUST HOLDINGS S.A.S (“ITRUST”). These licenses enable the propagation of the full range of cannabis varieties and further enable Procannmed to develop a complete offering of standardized, medicinal-grade formulations.Read The Full Article Here

What’s The Next Big Wave For MJ?With Canada’s recreational MJ indusrty recently being legalized, cannabis stocks are captivating the markets. And if you’ve been following along, you would have already seen that one particular MJ Stock could be making a new trend and we’ve got the details for you, here.Read The Full Report

Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of MAPH Enterprises, LLC owner of MarijuanaStocks.com and Leafbuyer Technologies, Inc, we were hired for a period from 2/2/2018 – 5/2/2018 to publicly disseminate information about (LBUY) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for & were paid “77,000” shares of restricted common shares. We own zero shares of (LBUY), which we purchased in the open market. Once the (6) Six month restriction is complete on 8/2/2018 we plan to sell the “77,000” shares of (LBUY) that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and Beleave Inc., Midam has been paid $200,000 from the company and ZERO shares of Beleave Inc. for a duration of 6 weeks beginning June 18, 2018 and ending July 31, 2018. We may buy or sell additional shares of (BLEVF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Continue reading
  7 Hits
  0 Comments
7 Hits
0 Comments

Hemp, Inc. (HEMP) Describes Booming Opportunity for Hemp in The Denmark News Coverage

Hemp, Inc. Describes Booming Opportunity for Hemp in The Denmark News Coverage of Wisconsin’s Newest Industry

Hemp, Inc. (OTC PINK: HEMP), a global leader in the industrial hemp industry with the largest multipurpose industrial hemp processing facility in the western hemisphere, announced today the company was featured in an article by The Denmark News regarding Wisconsin’s burgeoning hemp industry. In Wisconsin, hundreds of farmers are currently planting hemp on more than 2,000 acres. This is the first time in decades that farmers in Wisconsin have been able to plant hemp following the state’s passage of a law to grow industrial hemp late last year.

The article, “Hemp Industry Taking Root In Wisconsin,” details the many uses for hemp and how allowing the cultivation of hemp will allow farmers to diversify their portfolio of crops leading to a boost in revenue streams. In the article, Hemp, Inc. CEO Bruce Perlowin (also known as the King of Hemp)explains how hemp provides an environmentally-friendly and more cost-effective alternative to current wood pulp industry practices.

To see Bruce Perlowin’s latest Facebook video update on the 160-acre grow for each of the 160-acre Kins Domains to be built on each 500-acre Kins Community in states all over America and the world, click here.

Quoting Perlowin, The Denmark News reports: “In Brazil, there are spots where on the left you see the lush Amazon rainforest, and on the right it’s all flattened and destroyed,” said Perlowin, whose company opened a $20 million hemp fiber processing facility in Spring Hope, North Carolina last August. “In four months, you could have 12-foot tall hemp plants on all of that land, and then have it again in four months, instead of waiting years for trees to regrow.”

Perlowin told The Denmark News, “Kimberly-Clark better wake up and smell the bacon [and begin using hemp over wood pulp] as the number one paper producer, because if they don’t somebody will, and they’ll be the new number one.

Continue reading
  6 Hits
  0 Comments
6 Hits
0 Comments

The Changing State of Cannabis Legislation in the U.S.

The cannabis market in the U.S. thus far has seen a large amount of ups and downs as individual markets begin to find their place in the broad cannabis industry. Much of the trouble thus far has come from issues with legalization around the nation, but with positive remarks coming from many high up officials in the government, this sentiment could be changing over the course of the next few months to years.

Although it may seem bleak for the cannabis industry in the U.S. at times, the current market on cannabis is more developed than it has ever been before. There is a large amount of organic growth that is taking place to build the industry based on the positive public sentiment on cannabis and a need for reform on the current legislation in the industry. With a large and increasing bout of sales of the substance, many states in the U.S. are working on putting new framework in place to allow the sales of legal cannabis. The legalization of this industry could potentially mean billions in the form of tax revenue for the states as well as a large amount of individual revenue for the growers and those participating in the industry as a whole.

The U.S cannabis industry has been in a state of limbo for some time now as lawmakers work to make new legislation in the favor of the people. New polls have shown that as much as 60% or more of the U.S. is in favor of legalization which means that the national laws need to begin reflecting that. The state of legalization in the country has also made it extremely difficult for business in the industry to operate the way that any other business would. This has meant that companies in the space have been unable to get loans or even have bank accounts due to the federal law that prohibits them from even operating in the first place. As stated prior, one new poll has shown that those in favor of legalizing weed has gone up from 25% approval in 1995 to over 65% as of last year, and this number is continuing to change in favor of cannabis.

Up until the past few months, lawmakers have continued to share a similar sentiment regarding cannabis. This has been changing though as President Trump has potentially hinted at a support for new legalization around the nation. Trump recently stated while in an address at the G-7 summit in Canada, that he may be willing to support the legalization of the industry, at least on a statewide level. The President was asked about a new bill from Senators Cory Gardner and Elizabeth Warren regarding cannabis. He stated that “I support Sen. Gardner. I know exactly what he’s doing; we’re looking at it. But I probably will end up supporting that, yes.” This is the most positive sentiment from the highest official that has been received up until this point, and it seems as though things will continue to go in the industry’s favor.

The cannabis market in the U.S. and Canada still seems to be very much in its infant stages which means that there is a large amount of room to grow. As we move toward the future of legislation in North America for the whole of the industry, it will be interesting to see how lawmakers can help those who want to see weed be legalized in the U.S. and beyond. Only time will tell how well these efforts can continue to go.

Continue reading
  7 Hits
  0 Comments
7 Hits
0 Comments

Insider sees marijuana as $1.8 billion industry in Massachusetts - Cannabis News

The Bay State cannabis market will likely reach around $1.8 billion and it will take years to develop the cultivation infrastructure necessary to meet the demand, according to a business executive in the emerging field.

“It’s going to take time,” Tim Keogh, CEO of AmeriCann, said at a State House News Forum hosted with the Massachusetts Cannabis Business Association.

Based on Colorado’s legal marijuana market, Keogh projected that the cannabis market in Massachusetts could be around $1.8 billion.

Click here to read the compete article 

Andy Metzger ~ State House News Service via MetroWestDailyNews.com ~ 

Original link
  12 Hits
  0 Comments
12 Hits
0 Comments

How The Marijuana Market is Surprisingly Similar to The Tech Industry

The cannabis market has managed to remain incredibly lucrative over the course of the past several years, but with the advent of legalization and the changing public sentiment, it seems as though the market may just be getting started.

As far as the federal government is concerned, marijuana is still scheduled as a Schedule I narcotic, meaning that it has no potential for medicinal use as well as a high rate of addiction. Both of these claims have been widely refuted throughout the past several years by various medical professionals and scientific journals, thus the need for new laws and regulations.

According to one report “The cannabis plant produces more than 100 compounds (called cannabinoids), though most people know about just one. THC, short for tetrahydrocannabinol, is the psychoactive component that gets the user high. That is the drug that launched a counter-culture and the government campaign against it. It is also the recreational component.” A large amount of research is currently being conducted on one of the most important chemicals within the plant, CBD. CBD or cannabidiol has been hailed as having more potential to treat diseases than most other drugs currently on the market. CBD is also a non-psychoactive component of the plant, which in other words means that it does not get the user high. This is especially helpful in cases dealing with children, as the more mild the drug, the better.

Both of these compounds work individually, but they do have more of an effect when working with one another. Scientists have been working on creating a new series of drugs using the chemical CBD. In recent news, a new drug using components from the cannabis plant is scheduled to be voted on by the Food and Drug Administration in the U.S. to determine whether or not it should be allowed. The FDA has shown a considerable amount of positivity in terms of this new drug given how much potential it has shown to treat seizures in young children caused by a variety of illnesses. The drug is known as Epidiolex and is scheduled to be reviewed sometime in the near future.

Todd Harrison, founder, and CIO of CB1 Capital, a company that works within the marijuana industry stated recently that “legal weed, as some call it, has the wrong connotation. Tomorrow’s cannabis consumer won’t just smoke it; they’ll drink it, eat it, rub it on, take it as a pill, or wear it as a patch. They’ll take bubble baths in it.” This may at first sound like an exaggeration, but more and more companies have been working to come out with new solutions to using cannabis in the simplest ways. These new products have been working to shape the new industry, including new tech start-ups devoted to making the use of cannabis as easy as possible.

Continue reading
  11 Hits
  0 Comments
11 Hits
0 Comments

Marijuana Stocks to Look Out For as Canada Legalizes Recreational Cannabis

Canada recently approved legislation that will effectively allow recreational cannabis to be consumed and distrusted throughout the nation. This new legislation represents the first time a developed nation has legalized the adult-use of cannabis nationally, which is quite a large milestone as far as the industry is concerned.

The Prime Minister of Canada and avid supporter of legal cannabis, Justin Trudeau, recently stated that the new recreational laws will go into effect as soon as October 17th. The bill known as C-45 or the Cannabis Act was voted on as of Tuesday night, June 19th, and passed through the Senate vote with a large majority. Because of this, many stocks in the industry managed to climb in price, especially those concerned with the cannabis market in Canada.

The marijuana stocks at the top of the industry such as Canopy Growth (NYSE:CGC) have managed to come up in value by as much as 6.4% with others like the Cronos Group (CRON) moving up by around 5.25%. Many ETFs in the space also saw a rise in price with this news such as the ETFMG Alternative Harvest (MJ) which rose by around 2.35%. This is fair to assume however, as the market currently operates a lot on speculation given how new the industry still is. One of the other large players in the ancillary industry associated with cannabis is Scotts Miracle-Gro (NYSE:SMG). Scotts is a company that provides many different products for those attempting to grow cannabis whether it be outdoors or with hydroponic methods. The stock has come to light as the marijuana industry has changed so rapidly in the past several years.

Many Canadian stocks have been working to try and cement ties with the U.S. industry, such as the company Tilray, which filed on Wednesday for an IPO to list on the NASDAQ. The company released a statement that said “we are pioneering the future of medical cannabis research, cultivation, processing and distribution globally, and we intend to become a leader in the adult-use cannabis market in Canada once legalized. Many stocks in the cannabis industry have been working to come on board with the prestigious stock exchanges in the U.S. such as the listing of the Cronos Group earlier in the year. The company Aurora Cannabis, one of the largest marijuana producers in Canada, stated that they will be seeking new investments in the U.S. by utilizing a subsidiary as opposed to listing as a whole on the exchanges.

The company Aurora released a statement that “Recent changes in U.S. federal positioning with respect to cannabis have positively impacted the perception of risk to invest in U.S. cannabis assets,” Toronto Stock Exchange-listed Aurora said in a statement. “Entering the U.S. market now, in compliance with regulatory requirements, represents a risk/reward balance that is attractive to a well-connected and funded operators.”

Continue reading
  12 Hits
  0 Comments
12 Hits
0 Comments

Marijuana Stocks Newsletter – Happy Thursday – June 21, 2018

Good Morning & Happy Thursday! – 6/21/2018!

InCaseYouMissedIt: What Does Canada’s Legalization Mean For Pot Stocks?Unless you’ve been living under a rock, you know that the cannabis industry has been heating up for the last four years. A big move being made but our neighbors to the north could give investors one of the biggest calls to action with Canadian marijuana stocks taking center stage.Read The Full Article Here

Investing in the 2018 Cannabis MarketThe cannabis market throughout the past several years has managed to be extremely lucrative for those who have decided to invest. With new legal measures being put in place around the world and especially in North America, it seems like now is a better time than ever to look into the marijuana industry.Read The Full Article Here

What’s The Next Big Wave For MJ?With Canada’s recreational MJ industy recently being legalized, cannabis stocks are captivating the markets. And if you’ve been following along, you would have already seen that one particular MJ Stock could be making a new trend and we’ve got the details for you, here.Read The Full Report

This email is for ‘%%emailaddress%%’ You have received this email because you are subscribed to MarijuanaStocks.com | Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of MAPH Enterprises, LLC owner of MarijuanaStocks.com and Leafbuyer Technologies, Inc, we were hired for a period from 2/2/2018 – 5/2/2018 to publicly disseminate information about (LBUY) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for & were paid “77,000” shares of restricted common shares. We own zero shares of (LBUY), which we purchased in the open market. Once the (6) Six month restriction is complete on 8/2/2018 we plan to sell the “77,000” shares of (LBUY) that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and Beleave Inc., Midam has been paid $200,000 from the company and ZERO shares of Beleave Inc. for a duration of 6 weeks beginning June 18, 2018 and ending July 31, 2018. We may buy or sell additional shares of (BLEVF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Continue reading
  10 Hits
  0 Comments
10 Hits
0 Comments

Aphria Inc. (APHQF) Malta-based subsidiary, ASG Pharma, receives first import license for cannabis

Aphria’s Malta-based subsidiary, ASG Pharma, receives first import license for cannabis issued by the Malta Medicines Authority

Aphria Inc. (“Aphria” or the “Company“) (TSX: APH and US OTC: APHQF) today announced that its Malta -based subsidiary ASG Pharma (“ASG“), a high-capacity EU GMP-certified lab, is the recipient of the first import license for medical cannabis issued by the Malta Medicines Authority (“MMA“). The license will allow ASG to import medical cannabis for analytical testing and research and is an important step that will enable ASG to become a cornerstone in testing, research and development of medical cannabis in Europe .

” Malta’s legislative and regulatory standards are extremely rigorous, and we are pleased and proud that the MMA has awarded this import license to ASG,” said Antonio Costanzo , Head of International Development at Aphria. “ASG adheres to the highest international standards and we look forward to upholding this high bar as a leading European hub for medical cannabis.”

ASG Pharma is currently undergoing a multi-million-euro upgrade of its processing and manufacturing capabilities that will result in its ability to process, extract package and label pharmaceutical-grade medical cannabis and cannabis derivative products.

“Our EU GMP-certified lab in Malta will not only be a leading European center for R&D and testing, but also will provide a gateway to medical cannabis markets across Europe ,” said Vic Neufeld , CEO of Aphria. “We continue to pursue the most attractive strategic opportunities for medical cannabis in Europe and around the world, and this initial license sets the stage for ASG’s long-term future as Aphria’s processing, manufacturing and distribution hub for the entire continent.”

Continue reading
  10 Hits
  0 Comments
10 Hits
0 Comments

Investing in the 2018 Cannabis Market

The cannabis market throughout the past several years has managed to be extremely lucrative for those who have decided to invest. With new legal measures being put in place around the world and especially in North America, it seems like now is a better time than ever to look into the marijuana industry.

The weed market is still very much in its infant stages which means that there is a large amount of room to grow, as well as a large amount of information that comes only with time. Debra Borchardt, co-founder, and editor-in-chief of the Green Market Report states that one should first learn whether or not the company makes “any profits or have a realistic chance of making profits? Does it disclose all the critical information in an earnings press release? Who are the insiders and management team?” These are usually the first questions that one should ask before putting money into any stock let alone the cannabis market. Most companies in the industry are extremely transparent and have the majority of their financial information in easily accessible websites online. She continued to state that one should consider “the team, business model and revenue, and company history.” The common sentiment seems to be that someone should first look into the details of the company regarding financials, and who the team consists of. These should always be the most important factors in making a decision on whether to invest or not.

One of the newest things to look for in the growing cannabis market is the production capacities of a company. Since there are many different and large growers in the industry, one of the main things that continue to separate these companies is the amount of production that they are capable of. Many companies have been upping their output, especially in North America, given the new recreational legalization across Canada.

Borchardt states further that in regard to the Canadian market, “I think that the Canadian stocks are extremely overvalued and will correct at some point. The problem is that I can’t predict when that will happen.” Although many economists have echoed a similar opinion, it seems as though the first correction has potentially happened, given the state of the current market. Many have stated that there may be an issue with oversupply given the growing growth capacity with the anticipation of legalization, but this may be positive in the end. The overproduction could likely result in lowering prices of cannabis, which not only would bring more customers into the industry, but it would help one of the newest parts of the market; export.

Lastly, one of the main focuses of many investors looking to get into the industry has been through the ancillary markets that are associated with cannabis. These ancillary markets present a very solid way to make an introduction into the industry without a direct exposure to the market. The ancillary industries such as packaging, marketing and so on have managed to provide some of the best and most consistent returns in the industry as they are not as subject to volatility and market fluctuations as stocks that touch that physical cannabis plant.

Continue reading
  13 Hits
  0 Comments
13 Hits
0 Comments

Emblem Corp. (EMMBF) to Launch Emblem Germany in Joint Venture with Acnos Pharma

Emblem to Launch Emblem Germany in Joint Venture with Acnos Pharma

Emblem Corp. (EMC.V) (EMC-WT.V) (EMMBF) (“Emblem” or the “Company”), is pleased to announce that its Board of Directors has approved the Company’s formation of a joint venture under the name “Emblem Germany” (the “JV”) with German pharmaceutical wholesaler Acnos Pharma GmbH (“Acnos”) for the purpose of exporting Emblem branded cannabis products from Canada and importing them into Germany.  Subject to completion of definitive agreements with respect to the JV, the JV will be 60% owned by Emblem and 40% owned by Acnos.

With a population of approximately 82 million and federal health insurance coverage for medical cannabis, Germany’s adoption of cannabis has created one of the largest legal medical cannabis markets in the world.

Subject to all applicable regulatory approvals and the entering into of definitive agreements setting out the terms of the JV, Emblem will supply the JV with cannabis oil for sale to German pharmacies, wholesalers and clinical labs for medical purposes.  Teams from both companies are actively working to prepare and finalize definitive agreements setting out the terms of the JV, with the objective to commence export sales to Germany in 2019.

“Forming Emblem Germany with Acnos supports our market development efforts to establish world-class distribution channels in the regions where cannabis use is federally legal,” said Nick Dean, President and CEO of Emblem.  Upon completion, Emblem’s new 30,000 square foot Good Manufacturing Practices (“GMP”)-certified extraction facility will provide increased oil production capacity and significantly increase its extract and derivative product output to meet the expected demands of the German market.

“We have been impressed with the approach and progress Emblem’s medical division has made in establishing cannabis as a pharmaceutical product,” said Dirk Simonis, CEO of Acnos. “Emblem’s medical product innovation strategy is aligned to ours. We believe that medical cannabis products in Germany should be prepared in metered dose-controlled formats that physicians will feel confidence prescribing. From our experience, the long view of the German medical market is focused on oil extracts vs combustible products.”

Continue reading
  14 Hits
  0 Comments
14 Hits
0 Comments

Future Farm Technologies Inc. (FFRMF) Announces Shareholder Meeting Dates and Update Regarding NexTech Spin-Off

Future Farm Announces Shareholder Meeting Dates and Update Regarding NexTech Spin-Off

Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQX: FFRMF) is pleased to announce that the formal process for completing the distribution of 11,000,000 common shares of NexTech AR Solutions Corp. (“NexTech”) to the shareholders of Future Farm (the “Future Farm Shareholders”) on a pro-rata basis is now under way. The process began with the filing last week of a Notice of Meeting and Record Date for an Annual General and Special Meeting to take place on July 26, 2018.  That notice is available on the CSE.

The distribution of the NexTech common shares is to be completed pursuant to a court-approved Plan of Arrangement.  The next step in the process is the application for an Interim Order from the British Columbia Supreme Court. The application for the Interim Order was filed yesterday and is set for a court hearing on June 21. Upon receipt of the Interim Order the Company will proceed to mail to the Future Farm Shareholders a proxy circular disclosing detailed information on the business of NexTech.

If the Arrangement is completed, Future Farm Shareholders will receive a total of 11 million common shares of NexTech while maintaining their current ownership interest in Future Farm. NexTech will apply to list its shares on the CSE following completion of the Arrangement.

NexTech will focus on the advancement and development of its revenue generating portfolio of gaming and all-in-one apps known as the “All-In-One-App Portfolio” using its augmented reality technology. NexTech has also expanded its augmented reality technology products and is working with a number of clients for the provision A/R enhanced marketing services including through its Native AR Platform and AR learning model.

The securities referenced in this news release have not and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Continue reading
  13 Hits
  0 Comments
13 Hits
0 Comments

Aphria Inc. (APHQF) Applauds Passage of Bill C-45, a Historic Milestone for Canada and the Cannabis Industry

Aphria Applauds Passage of Bill C-45, a Historic Milestone for Canada and the Cannabis IndustryAphria Inc. (“Aphria” or the “Company“) ( TSX: APH and US OTC: APHQF) today provided the following statement in response to the passage of Bill C-45, the Cannabis Act:

Vic Neufeld , CEO of Aphria, said, “This is a historic milestone for our industry and for our country that will reverberate around the world as Canada solidifies its progressive leadership on cannabis. We are pleased to now have a regulatory framework for adult-use cannabis in place that sets the groundwork for the continuing evolution of this rapidly expanding industry. We applaud the Government’s consistent and conscientious efforts to protect public health and safety, restrict access to youth and eliminate the black market.”

“Today also represents an important milestone for our business, for which all of us at Aphria have been eagerly awaiting,” said Neufeld. “Thanks to the dedication of our incredible team, and our focus on innovation, R&D and our unmatched ability to grow high-quality, clean and safe cannabis to scale, we are ready to hit the ground running. Backed by our annualized production capacity of 255,000 kg by early next year, we are well prepared to the meet the anticipated demand in the adult-use market while continuing to serve the ongoing needs of our medical cannabis patients. We look forward to continuing to work with the Government as a long-term partner to evolve the industry in Canada and further its global success story.”

“We would like to acknowledge the work of government, industry, partners and all of our employees in getting us to this stage. As a country, we are already leading the way in medical cannabis, and it is thanks to the collaboration and diligence of all involved that we now have the opportunity to break new ground and set the standard for a successful adult-use cannabis regime in Canada .”

We Have A Good Thing Growing

About Aphria

Continue reading
  13 Hits
  0 Comments
13 Hits
0 Comments

What’s The Deal With Cannabis Oils?

Cannabis oil and other derivatives from the marijuana plant have been around for some time now, but with new methods of research and a growing legal market, it seems that cannabis oils are bigger than ever. The cannabis market has been growing in legality in North America and around the world over the course of the past several years, and the new legal state of the plant has meant that more companies than ever are looking into how they begin to produce large amounts of cannabis oils.

First off, cannabis oils are the extracted chemicals from the cannabis plant, which when unprocessed contain around 100 or so active ingredients which all combine to help give many of the medical benefits of smoking cannabis in its natural form. According to one report “The two main active substances in cannabis plants are cannabidiol, or CBD, and delta-9 tetrahydrocannabinol, or THC. Oil extracted from hemp plants can contain a lot of CBD, while oil from skunk plants will contain far more THC. THC produces the high that recreational cannabis users seek, while oils for medical use contain mostly CBD.”

One of the most prominent reasons to use cannabis oils and extracts is the fact that the dosing is much easier to control and monitor as opposed to dried cannabis. The amounts of THC and CBD in the plant are very easily controlled in this method, and thus this information can be given to the patient to help ensure that they are getting the most quality medicine with the correct information.

In terms of medicinal benefits, the two main components of cannabis, THC, and CBD both have their own varying properties. CBD can work as an anticonvulsant, which means that it can be used to help reduce the frequency of seizures. CBD also has no psychoactive properties, which means that it does not get the user high. This helps to make the case for CBD being a promising treatment for children who have epileptic seizures but want an alternative to the traditional harsh pharmaceuticals that are often prescribed.

The industry on cannabis extracts has also been working to merge this with that of the pharmaceutical market. Many big companies have been researching new ways to include cannabis oils in pharmaceuticals to help with a wide variety of conditions and ailments. In recent news, the Food and Drug Administration will be considering whether or not to approve the drug Epidiolex, which is a CBD-derived medicine that can help to fight seizures. Around the world, many governments have been working to attempt to find some sort of legalization or fair legislation that would allow these patients to get the help that they need. The European Medicines Agency is scheduled to state a ruling on whether or not the drug should be legalized within the European Union, but that is all that has been said up to this point.

Continue reading
  14 Hits
  0 Comments
14 Hits
0 Comments

Hemp, Inc. (HEMP) Applauds Senate Agriculture Committee for Passing Farm Bill with Hemp Legalization

Hemp, Inc. Applauds Senate Agriculture Committee for Passing Farm Bill with Hemp Legalization

Hemp, Inc. (OTC PINK: HEMP), a global leader in the industrial hemp industry with the largest multipurpose industrial hemp processing facility in the western hemisphere, announced today the company applauds the Senate Agriculture Committee for passing last Wednesday the 2018 farm bill in a 20-1 vote. The farm bill includes hemp legalization that is backed by Senate Majority Leader Mitch McConnell.

According to McConnell, hemp farming in Kentucky can help replace some of the revenue from falling tobacco demand, reported CNBC.

“I know there are farming communities all over the country who are interested in this,” said McConnell, according to CNBC. “Mine are particularly interested in it, and the reason for that is — as all of you know — our No. 1 cash crop used to be something that’s really not good for you: tobacco. And that has declined significantly, as it should, given the public health concerns.”

Officially known as the Agriculture Improvement Act of 2018, the draft farm bill contains more than 1,000 pages and covers everything from farm subsidies and food stamps to trade and rural development policy. Farmer assistance includes commodity payment programs, as well as subsidized crop insurance.

Hemp, Inc. announced its support in April for Senate Majority Leader Mitch McConnell’s introduction of a bill to remove industrial hemp from the federal government’s schedule of controlled substances.

Continue reading
  9 Hits
  0 Comments
9 Hits
0 Comments

Marijuana Stocks Newsletter – June 20, 2018 – Happy Wednesday!

Good Morning & Happy Wednesday! – 6/20/2018!

SPECIAL REPORT: Canada’s Legalization Means Big Things for Pot StocksUnless you’ve been living under a rock, you know that the cannabis industry has been heating up for the last four years. A big move being made but our neighbors to the north could give investors one of the biggest calls to action with Canadian marijuana stocks taking center stage.Read The Full Article Here

How the Marijuana Market is Becoming InternationalCannabis legalization has been present in the U.S. and abroad for some time now, but lawmakers and companies are working to see how the market in North America could potentially work with the international industry of cannabis.Read The Full Article Here

What’s The Next Big Wave For MJ?With Canada’s recreational MJ industy recently being legalized, cannabis stocks are captivating the markets. And if you’ve been following along, you would have already seen that one particular MJ Stock could be making a new trend and we’ve got the details for you, here.Read The Full Report

This email is for ‘%%emailaddress%%’ You have received this email because you are subscribed to MarijuanaStocks.com | Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of MAPH Enterprises, LLC owner of MarijuanaStocks.com and Leafbuyer Technologies, Inc, we were hired for a period from 2/2/2018 – 5/2/2018 to publicly disseminate information about (LBUY) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for & were paid “77,000” shares of restricted common shares. We own zero shares of (LBUY), which we purchased in the open market. Once the (6) Six month restriction is complete on 8/2/2018 we plan to sell the “77,000” shares of (LBUY) that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and Beleave Inc., Midam has been paid $200,000 from the company and ZERO shares of Beleave Inc. for a duration of 6 weeks beginning June 18, 2018 and ending July 31, 2018. We may buy or sell additional shares of (BLEVF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

Continue reading
  13 Hits
  0 Comments
13 Hits
0 Comments

How the Marijuana Market is Becoming International

Cannabis legalization has been present in the U.S. and abroad for some time now, but lawmakers and companies are working to see how the market in North America could potentially work with the international industry of cannabis. One of the biggest pieces of news to influence this has been Canada’s decision to legalize recreational and medicinal cannabis on a nationwide level. The country has been one of the main contributors to the idea of taking the market to the International level, but there are still some things that need to happen prior to that. Many companies within Canada, however, have already started to create these ties abroad, and here are just a few.

One of the most promising parts of the global cannabis industry has been the advent of the possibility that Africa could begin exporting cannabis across the continent. Africa as a whole has already stated that they grow somewhere around nine million kg of weed per year, but this growth has largely been not accounted for nor taken advantage of. Some nations such as Ghana, allow the use of cannabis on a non-legal level, but the possession of the plant is still illegal. Only two African nations allow the use of cannabis legally and those are Zimbabwe and Lesotho.

Lesotho has been on the radar of the market for some time now, as the conditions in the nation are quite well suited to grow cannabis. The country receives sunshine for around three hundred days out of the year which coupled with a high amount of humidity and warmth, makes it the perfect place to grow cannabis.

Aphria (TSX: APH) has been working to cement ties with Africa since a few months back when they began reaching out to the legal market in Lesotho. The company entered a joint venture with the company Verve Dynamics, with cost around $3 million to do. The two companies will help to bring the high-grade, low-cost cannabis from Verve Dynamics that is grown in Africa, to various markets around Europe and North America. The joint venture will effectively be known as CannInvest Africa and is poised to create a large amount of interest throughout the whole of the market.

Another company that has been interested in growth in Africa has been the large Canadian marijuana grower Canopy Growth Corporation (TSX:WEED), (NYSE:CGC). The company recently acquired the African company Daddy Cann Lesotho, which currently is trading under the name “Highlands”. The acquisition results in Canopy issuing around $30 million in shares, but this deal could help to give Canopy access to a population of over 55 million people, which could make it quite worth it in the future.

Continue reading
  14 Hits
  0 Comments
14 Hits
0 Comments

 Tetra Bio-Pharma Inc. (TBPMF) Adds a New Leader for its Commercial Operations

Tetra Bio-Pharma Adds a New Leader for its Commercial Operations

 Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX VENTURE:TBP) (TBPMF), is pleased to announce that Mr. Richard Giguere has been hired as Executive Vice-President, Commercial Operations. He will be responsible for the commercial sales and operations of Tetra Natural Health and Tetra Veterinary Health.

Richard has more than 20 years’ experience in sales and marketing in the pharmaceutical industry from coast to coast. During his career, he has held various business development, management and negotiation positions and launched several new products on the Canadian market. He has worked for various pharmaceutical companies in sectors such as generics, branded products and medical devices. He has also worked with OTC, natural products and original medications. Richard is recognized for his deep ethical sense, respect of others and talent for developing long-term business relationships through flexibility and efficiency. In the past 10 years, he was also a board member at the companies for which he worked.

“We’re very proud to add Richard Giguere to our senior management team. His vast experience in the sales and marketing of OTC, natural health products and original medications in the pharmaceutical industry across Canada will help drive the execution of our corporate strategy for our Tetra Natural Health and Tetra Veterinary Health divisions,” says Guy Chamberland, Interim Chief Executive Officer of Tetra Bio-Pharma.

Richard Giguere’s arrival is perfectly aligned with Tetra Bio-Pharma’s decision to restructure its corporation by commercial markets. While Tetra Bio-Pharma will be dedicated to pharmaceutical development and commercialization of cannabinoid-based prescription drugs and treatments, Tetra Natural Health will develop and sell cannabinoid-based OTC (self-care) products to leverage the post-legalization market and Tetra Veterinary Health will focus on commercialization of cannabinoid-based products for the pet product market.

“I am honored to be able to play an active role in growing both the Tetra Natural Health and Tetra Veterinary Health divisions,” says Richard Giguere, EVP, Commercial Operations. “Tetra has a sound business model, and there are significant opportunities for us to grow our two commercial divisions. I am committed to making the best business and commercial decisions to accelerate the development of these huge potential markets for our cannabinoid-based products.”

Continue reading
  14 Hits
  0 Comments
14 Hits
0 Comments

iMD Companies, Inc. (ICBU) Gives Corporate Update to Shareholders

iMD Companies, Inc., Gives Corporate Update to ShareholdersiMD Companies, Inc. (OTC PINK: ICBU) Board of Directors announced today that the company is completing its financials and expects to upload them to OTC Markets by next week. The company has submitted its application and payment to OTC Markets and expects the application to be approved this week. The company recently completed two acquisitions, SG Minerals Mining Company and LCG Plastech, a PVC pipe manufacturing Company. Both companies are wholly owned subsidiaries of iMD. The company had to wait until the audited financials were completed by both companies in order to complete the companies financials and disclosures. The financials have now been assembled and iMD expects to file with OTC Markets to become current in the upcoming week. iMD is pleased that the financials have been completed and both companies are headed in the right direction with increasing revenues and contracts. The company is also currently working on acquiring Gold mining claims and mines to add revenue and assets to the companies consolidated income statements and will update the shareholders as soon as completed.

About iMD Companies, Inc. www.imdcompaniesinc.com

iMD Companies, Inc., (ICBU) is a Florida corporation, engaged in the manufacturing, extraction and distribution in the mining industries and asset accumulation of revenue producing companies. The company is positioned to be a holding company for acquisitions in the mining industries. The company and the principals of the management team have extensive backgrounds in finance, manufacturing, marketing and distribution. ICBU’s goal is to create and increase shareholder value by tactically growing our business while strategically seeking to acquire new business and create other business alliances, which generate increased revenues and earnings.

Safe Harbor Statement:

Certain statements made in this press release constitute forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements.

-222-2863

Continue reading
  12 Hits
  0 Comments
12 Hits
0 Comments

Choom™ (CHOO.CN) (CHOOF) Secures 10 Additional Cannabis Retail Opportunities

Choom Secures 10 Additional Cannabis Retail Opportunities in Alberta and British Columbia

Choom (CHOO.CN) (CHOOF) (the “Company” or “Choom”) an emerging, fully-integrated cannabis company, is pleased to announce that it has advanced the build-out of its cannabis retail store network in Alberta and British Columbia .

Choom has secured the rights to an additional 7 retail locations in Alberta . Choom has 25 leases in highly strategic and secure locations in Alberta with 24 applications submitted. Choom has also secured 3 additional B.C. retail leases, combined with the existing 7, for a total of 10 retail opportunities in B.C. In all cases, the retail opportunities are subject to all necessary governmental and municipal approvals being granted. This number is expected to grow over the coming months as the Company is currently negotiating additional leases with the intention of submitting applications for retail licenses. The following link will bring you to our retail opportunity map: https://investors.choom.ca/wp-content/uploads/2017/11/ChoomRetailMap.pdf

“This is a significant step towards establishing Choom’s strategy to be a leading private cannabis retailer in Canada ,” states Choom’s President and CEO, Chris Bogart . “Market share and customer acquisition in the upcoming recreational landscape will be very difficult to come by, these applications are key to Choom’s retail strategy. Choom’s brand was created exclusively for the recreational market, core to our values is cultivating a great experience for the consumer and part of this strategy is retail distribution. We are committed to pursuing retail licensing opportunities across the country and remain focused on cultivating ‘Good Time with Good Friends’.”

SAY HELLO TO CHOOMTMChoom was created for and inspired by the Choom Gang; a group of buddies in Honolulu during the 1970’s who loved to smoke weed—or as the locals called it, “Choom”. Now, after four decades, Choom is bringing the spirit of Hawaii to Canada . Choom is focused on delivering an elevated customer experience through our curated retail environments, high-grade handcrafted Cannabis supply, and a diversity of brands for the Canadian recreational consumer.

We’re planting our flag in the rapidly growing legal cannabis industry in Canada with our own brand of high-grade handcrafted herb. For additional information please visit us at: www.choom.ca

Continue reading
  9 Hits
  0 Comments
9 Hits
0 Comments

Comparing Some of the Top Players in the Marijuana Stock Market

The marijuana market has been extremely lucrative for some time now, but with new legislation across North America and abroad, many companies have come to the forefront of the industry showing new ways to grow and export cannabis that has never been done before.

The companies CannTrust Holdings (NASDAQOTH:CNTFF) and Organigram Holdings (NASDAQOTH:OGRMF), have both been some of the largest players in the cannabis growing space. The two companies share a large amount of similarities including being from Canada and sharing a similar trajectory, but both companies still present a very interesting case to investors.

The two companies are in no way the same, but investors have compared them greatly over the past year or so. CannTrust has been at the forefront of the weed revolution in Canada for some time now, and recently posted earnings of around $11.4 million Canadian dollars in their first quarter. This makes this quarter the third consecutive quarter of taking in profits.

One of the biggest factors of growth for CannTrust has been that they take in 60% of their sales from cannabis extracts, which has been a market that has frown very quickly. The sales are also growing very rapidly for CannTrust, which means that the next quarter’s revenue could potentially continue to show a large amount of profit.

The company has yet to move into the international market as many other Canadian giants have done, so currently, all of their profits have come from the domestic market in Canada. The company recently teamed up with another cannabis company known as Apotex, which is the largest pharmaceutical company of generic drugs in Canada, and listed as the seventh largest throughout the world. CannTrust has also been working to grow their business domestically due to the impending recreationally legal market that has been growing there for some time now.

Continue reading
  10 Hits
  0 Comments
10 Hits
0 Comments

Marijuana Stocks Newsletter Tuesday, 6/19/2018

READ THIS: Canada’s Legalization Means Big Things for Pot Stocks

Unless you’ve been living under a rock, you know that the cannabis industry has been heating up for the last four years. A big move being made but our neighbors to the north could give investors one of the biggest calls to action with Canadian marijuana stocks taking center stage.

Read The Full Article HereDon’t Mess with Texas: Texan Republican Party announced backing of industrial hemp and they’re not backing down

45 years ago, those in possession of marijuana in Texas faced a charge of life in prison; on Saturday, however, Texan Republican Delegates voted to endorse the decriminalization of industrial hemp.

Read The Full Article HereWhat’s The Next Big Wave For MJ?

With Canada’s recreational MJ industry recently being legalized, cannabis stocks are captivating the markets. And if you’ve been following along, you would have already seen that one particular MJ Stock could be making a new trend and we’ve got the details for you, here.

Read The Full Report

Disclaimer:

Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of MAPH Enterprises, LLC owner of MarijuanaStocks.com and Leafbuyer Technologies, Inc, we were hired for a period from 2/2/2018 – 5/2/2018 to publicly disseminate information about (LBUY) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for & were paid “77,000” shares of restricted common shares. We own zero shares of (LBUY), which we purchased in the open market. Once the (6) Six month restriction is complete on 8/2/2018 we plan to sell the “77,000” shares of (LBUY) that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Continue reading
  10 Hits
  0 Comments
10 Hits
0 Comments

Marijuana in the workplace: Balancing competing obligations - Cannabis News

As an employer, you may have an obligation to accommodate employees who use marijuana for medical reasons, or you may want to relax your policies to cope with a talent shortage.

It’s a Catch-22 with big implications for your workplace: Marijuana is a Schedule I controlled substance under federal law — in other words, illegal.

Yet many states have legalized marijuana for medicinal and even recreational use, with new laws being passed all the time.

Click here to read the complete article

Jennifer Carsen ~ HRDive.com ~ 

Original link
  12 Hits
  0 Comments
12 Hits
0 Comments

Don’t Mess with Texas: Texan Republican Party announced backing of industrial hemp and they’re not backing down

45 years ago, those in possession of marijuana in Texas faced a charge of life in prison; on Saturday, however, Texan Republican Delegates voted to endorse the decriminalization of industrial hemp.

According to Civilized.com, those convicted of marijuana possession in 1923 Texas paid a steeper price. It wasn’t until 50 years later that the state changed those laws. Today, Texas’ state law says that possession of up to two ounces is a criminal offense punishable by incarceration of up to six months and a $2,000 fine. In a state where the drug was once banned, this recent vote from Delegates at the Republican Party of Texas Convention ahead of the 2019 legislative session could change all that. In addition to formulating platforms upon which marijuana decriminalization, industrial hemp, and medical marijuana would be endorsed, Republicans also agreed to rally behind change for the way the federal government classifies the drug.

Currently, marijuana is seen as a Schedule 1 drug, on the same level as heroin and LSD. Despite the federal viewpoint on the classification of this controversial drug, more and more states continue to legalize the use of the plant in one way or another. In 2015, Senate Bill 339, also known as the Texas Compassionate-Use Act, affirmed that low-THC could be distributed to patients who qualify for medical marijuana as treatment. Saturday’s vote further delved into the party’s positions on medical marijuana which patients currently have limited access to.

Last year, the vote to increase the access of medical marijuana to patients received massive support. The legislative session, however, ran out of time before floor votes could be conducted. With the next legislative session beginning in January, cannabis backers hope that the increased Republican support will give the issue the traction it needs to push it over the edge. One of the new positions taken by the party also recognizes the plant’s value as an agricultural commodity. In it, they implore Texas Legislature to pass legislation on the drug that would permit the sale, cultivation, and manufacturing of industrial marijuana and marijuana-related products. Additionally, they encourage that the law is changed so that marijuana possession is no longer classified as a criminal offense, but a civil one. This means that legal adults, aged 21 years and older, found with up to one ounce of marijuana on their person would be punished by a $100, but go without having to serve a jail sentence.

As it would seem, marijuana has some friends in high places, and it only appears to be rallying more Republican supporters as opinions shift. U.S. Senate Majority Leader Mitch McConnell recently pushed for the 2018 Farm Bill and President Trump announced this month that he would back bipartisan efforts to lift the federal ban on the drug so that states could regulate their own cannabis laws. With Texas currently arresting tens of thousands of its citizens for marijuana-related crimes each year, this change in opinion is a major breakthrough for cannabis advocates. However, for as many allies as the drug has, there are still those who oppose it. An avid adversary to marijuana legalization is one of Texas’ own, Republican Rep. Pete Sessions. Despite his party’s recent support of the drug, Sessions has used his position as chairman of the House Rules Committee to block marijuana votes. These include a vote that, if passed, would have given veterans access to marijuana as a treatment for symptoms of PTSD, pain management, and other conditions. Sessions’ actions to impede marijuana legalization can only hold on for so long as more conservatives come out in support of the drug. Considering the party’s ongoing and turbulent history of opposition, these new positions by Republicans comes as a surprise to many but also signifies something of greater importance. Has the fact that the drug has gone mainstream shifted political views enough to bring the country that much closer to full-blown legalization?

Continue reading
  11 Hits
  0 Comments
11 Hits
0 Comments

MJ Stocks Newsletter Monday, 6/18/2018

Canada’s Legalization Means Big Things for Pot Stocks

Unless you’ve been living under a rock, you know that the cannabis industry has been heating up for the last four years. A big move being made but our neighbors to the north could give investors one of the biggest calls to action with Canadian marijuana stocks taking center stage.

Read The Full Article HereChoom (CHOOF) Announces Closing of $10.1 million Private Placement

Choom (CSE: CHOO; OTCQB: CHOOF) (the “Company” or “Choom”), an emerging fully-integrated cannabis company, is pleased to announce it has closed its previously announced non-brokered private placement ( June 13, 2018 ). The Company issued 14,225,352 shares for total gross proceeds of $10.1 million. Aurora Cannabis is the cornerstone investor in the placement with a lead order of $7 million. All securities issued are subject to a four-month hold period.

Read The Full Article HereWhat’s The Next Big Wave For MJ?

With Canada’s recreational MJ industry recently being legalized, cannabis stocks are captivating the markets. And if you’ve been following along, you would have already seen that one particular MJ Stock could be making a new trend and we’ve got the details for you, here.

Read The Full Report

Disclaimer:

Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of MAPH Enterprises, LLC owner of MarijuanaStocks.com and Leafbuyer Technologies, Inc, we were hired for a period from 2/2/2018 – 5/2/2018 to publicly disseminate information about (LBUY) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for & were paid “77,000” shares of restricted common shares. We own zero shares of (LBUY), which we purchased in the open market. Once the (6) Six month restriction is complete on 8/2/2018 we plan to sell the “77,000” shares of (LBUY) that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Continue reading
  16 Hits
  0 Comments
16 Hits
0 Comments

Canada’s Legalization Means Big Things for Pot Stocks

Unless you’ve been living under a rock, you know that the cannabis industry has been heating up for the last four years. A big move being made but our neighbors to the north could give investors one of the biggest calls to action with Canadian marijuana stocks taking center stage.

Canada is likely to legalize recreational marijuana this summer, which could be a big catalyst for cannabis stocks and right now investors interested in pot stocks should pay close attention to the industry, heading into this big move. But what’s the name of the game for 2018?

It would seem that acquisitions and investment deals are fueling the fire so for investors looking for opportunity, the very key could be finding companies that are building a brand & real niche marketplace for themselves.

Case and point, just look at what has happened within the last 8 months.  Back in October, it was widely publicized that one of the largest beer, wine, and spirits companies in the world, Constellation Brands (STZ) was going to acquire a minority (9.9%) stake in Canopy Growth (CGC).

Had you invested in Canopy back when it was just beginning to put the wheels in motion, you would have seen a stock trading around $1.30. Today that same “small cannabis company” trades at a price of over $30 per share! So what could be the next “Canopy” opportunity?

Continue reading
  11 Hits
  0 Comments
11 Hits
0 Comments

Aurora Cannabis Inc. (ACBFF) Closes Strategic Investment in Choom Holdings

Aurora Cannabis Closes Strategic Investment in Choom Holdings

Aurora Cannabis Inc. (“Aurora” or the “Company”) (ACB.TO) (ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) announced today that it has closed its previously announced $7 million investment in Choom Holdings Inc. (“Choom”), whereby Aurora received 9,859,155 common shares from Choom’s treasury, priced at $0.71 per share, representing a 6% ownership interest. In total, Choom issued 14,225,352 shares for total gross proceeds of $10.1 million . All securities issued are subject to a four month hold period.

Since the announcement of the private placement, Choom closed its previously announced acquisition of Specialty Medijuana Products Inc. (“SMP”). SMP recently completed construction of its 10,000 square foot Sooke, British Columbia facility and expects to receive its cultivation license from Health Canada in the third quarter of 2018. In addition, SMP intends to expand production capacity by and additional 19,600 square feet at the Sooke facility, bringing the total capacity to 29,600 square feet. SMP has also submitted plans to construct two separate hybrid greenhouse facilities on the grounds of the Sooke Facility, which when completed would bring total production capacity to over 700,000 square feet.

Management Commentary

“This strategic investment positions Aurora to participate in the emerging craft cultivation market, as well as in an exciting Western Canada retail strategy with a seasoned team of executives,” said Terry Booth , CEO of Aurora. “Choom’s product cultivation strategy puts the cultivar first, developing a high-grade offering with unique flavour profiles, which are anticipated to resonate strongly with the adult-use consumer market, once legalized. We’re pleased to close our investment in Choom, and look forward to building a strong, long-term relationship with the team.”

Chris Bogart , President & CEO for Choom, added, “The financing provides us with the funds to accelerate the execution of our unique retail strategy moving forward. We are now well positioned to expand our production and retail footprint, and pursue further opportunities across Canada .”

Continue reading
  8 Hits
  0 Comments
8 Hits
0 Comments

How the Cannabis Industry is Becoming More Diversified

The cannabis industry has managed to draw a large amount of attention over the past few years or so, but a little-known fact throughout the market comes from the lacking representation of minorities in the industry.

Shanita Penny, the president of the board of directors for the Minority Cannabis Business Association, took a complaint following a racially motivated naming of a cannabis strain. The organization run by Penny, ha the goal of diversifying the cannabis industry to help give a more accurate representation of those who are involved in the market. She stated that the marijuana industry around the country is still overwhelmingly run by a white majority. One study states that around less than one percent of owners of marijuana dispensaries in the U.S. are owned by black people. Another survey states that “less than 19 percent of the nation’s marijuana businesses have minority investors. With the federal prohibition of marijuana still in place, data remains woefully inadequate on the exact makeup of the nation’s marijuana business owners. But if the last survey is accurate, that means a whopping 81 percent of the nation’s marijuana businesses are white-owned.”

This number is something that undoubtedly needs to be changed as the U.S. is a diverse country full of people from all types of backgrounds. Congresswoman Barbara Lee, a Democrat from California states that she will be introducing something known as the RESPECT Resolution. This is the first piece of legislation introduced into congress to help solve the racial disparity in the cannabis industry. She stated that her goal is to try to encourage states to bring those who are underrepresented, into the industry in larger numbers. This way, the industry as a whole can grow in greater numbers.

The resolution means that states and localities will effectively be able to have the ultimate decision on what happens, but they can choose to vote on it individually. She has stated that she is confident that it will send a large signal to lawmakers who are wishing to make a change in the industry.

The legislation would also effectively “urge states to completely expunge the records of people incarcerated for non-violent marijuana offenses. It also asks them to drop the fees to even apply for a marijuana license (like New York’s $10,000 non-refundable fee), to allow people formerly incarcerated for marijuana to access this new marijuana regulatory system.” Some states like Illinois, an individual with a felony record cannot even have a shot at getting a marijuana card, which given the racial inequality in terms of jailed demographics, this makes it seem that much more unjust.

Continue reading
  8 Hits
  0 Comments
8 Hits
0 Comments

Big Deals Are Emerging In The Canadian Marijuana Space

The Canadian cannabis market has been explosive for many reasons over the past several years, but most notably the state of legal cannabis has meant that investors have continued to flock into the market. This influx of capital has led to a large amount of market growth in a short period of time, and has also led to a high amount of mergers throughout the industry. Canada recently voted to allow recreational cannabis for anyone over the age of 21, and this new bill will go into effect some time in the coming months.

The legal cannabis market in Canada will effectively be able to add as much as $5 billion in revenue to the market and that is the lowest estimate. This also means a lot more money going back into the pockets of producers, who can then use these profits to continue growing the industry even further.

One of the main issues in the industry has been the attempt to get legitimate capital from banks or other financial institutions. According to one report “Canadian banks have almost universally stayed away from the weed industry in Canada for fear of criminal and/or financial penalties associated with offering basic banking services to pot stocks.” This type of taboo surrounding cannabis is nothing new and is simply a product of the past hundred or so years of cannabis in the media.

The only option for these companies to raise capital has been through the listing of Canadian stocks and bought-deal offerings. This means according to one report that it is “a means to raise capital by selling common stock, convertible debentures, stock options, and/or warrants to an investor or group of investors prior to the release of a prospectus. Bought-deal offerings have been widely successful in raising capital that pot stocks have used to grow their production capacity. In fact, this past week, one giant marijuana stock announced what’s now the largest bought-deal offering in the history of the Canadian weed industry.”

The company Aphria has continued to be at the top of the cannabis market and recently became the subject of the largest bought deal financing offer to happen in several years. The bought-deal agreement will mean that around 19 million shares of common stock will be “ sold for $11.85 Canadian dollars ($9.13 U.S. dollars) per share. An underwriters’ option exists as well that could allow for an additional 2.84 million shares to be purchased. Without the underwriters’ option, this is a CA$225 million offering ($173.3 million). Including the underwriters’ option, assuming it’s exercised, this is a CA$258.8 million offering ($199.4 million).” This deal is quite massive considering the recent bought-deal financing of around CA$200 million from Aurora and Canopy Growth that went on a few months ago.

Continue reading
  11 Hits
  0 Comments
11 Hits
0 Comments

Choom™ (CHOOF) Announces Closing of $10.1 million Private Placement

Choom Announces Closing of $10.1 million Private Placement

Choom (CSE: CHOO; OTCQB: CHOOF) (the “Company” or “Choom”), an emerging fully-integrated cannabis company, is pleased to announce it has closed its previously announced non-brokered private placement ( June 13, 2018 ). The Company issued 14,225,352 shares for total gross proceeds of $10.1 million . Aurora Cannabis is the cornerstone investor in the placement with a lead order of $7 million . All securities issued are subject to a four month hold period.

“The financing provides us with the funds to accelerate the execution of our unique retail strategy moving forward.” States Chris Bogart , CEO and President of Choom. “We are now well positioned to expand our production and retail footprint, as well as, pursue further opportunities across Canada .”

None of the securities issued in connection with the placement will be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), and none of them may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This news release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there by any sale of the securities in any state where such offer, solicitation, or sale would be unlawful.

SAY HELLO TO CHOOMTM

The Choom brand is inspired by Hawaii’s “Choom Gang”- a group of buddies in Honolulu during the 1970’s who loved to smoke weed—or as the locals called it, choom. Evoking the spirit of the original Choom Gang , our brand is synonymous with cultivating good times with good friends. We are focused on delivering an elevated customer experience through our curated retail environments, high-grade handcrafted cannabis supply, and a diversity of brands for the Canadian recreational consumer.

Continue reading
  9 Hits
  0 Comments
9 Hits
0 Comments

Grow Condos, Inc.,(GRWC) Fully Retires Convertible Debt

Grow Condos, Inc. Fully Retires Convertible Debt

Grow Condos, Inc.,(GRWC) announces that all notes issued pursuant to the Company’s 2016 debt offerings have been retired and the Company has no further obligations under the notes of those offerings. “We’re excited to have this convertible debt fully retired as we continue to strengthen Grow Condos’ balance sheet and drive shareholder value,” Chief Executive Officer Wayne Zallen stated. “Our stock had been under enormous pressure due to the large amount of debt converted into shares and introduced into the market, and the dilution of the stock has been a concern to us and all of our shareholders. To see the conclusion is a relief to all of us. We are aware that going forward we will need to generate sufficient revenues to become self-financing. Should we need capital to fund future operations, we will strive to be more judicious in the terms of such financing.  We are confident that this approach will result in better shareholder value.”

About Grow Condos, Inc.: Grow Condos is a publicly traded company listed under the symbol GRWC.  We own and manage a 15,000-square foot condo style warehouse in Eagle Point, Oregon, Smoke On The Water, a 420 friendly campground located in Lake Selmac, Oregon, and a property in Eugene, Oregon.

Safe Harbor: This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Grow Condos, Inc, its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Grow Condos, Inc.’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in Grow Condos, Inc. filings with the OTC Markets, Securities and Exchange Commission and/or the company’s website.

CONTACT:Grow Condos, Inc.Corporate: www.growcondos.comTwitter: https://twitter.com/GrowCondosIncInvestor Relations: 

The post Grow Condos, Inc.,(GRWC) Fully Retires Convertible Debt appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Original link
  10 Hits
  0 Comments
10 Hits
0 Comments

Marijuana Stocks Newsletter – Happy Friday June 15, 2018

Good Morning & Happy Friday! – 6/15/2018!

Choom (CHOOF) Announces Closing of Specialty Medijuana ProductsChoom (CSE: CHOO; OTCQB: CHOOF) (the “Company” or “Choom“), an emerging fully-integrated cannabis company, is pleased to announce that today it is closing its acquisition (the “Transaction“) of Specialty Medijuana Products Inc. (“SMP“) pursuant to an amended and restated amalgamation agreement among Choom, Arbutus Brands Inc. and International Tungsten Inc. The Company announced the definitive agreement to effect the Transaction in a news release on March 19, 2018.Read The Full Article Here

What’s The Next Big Wave For MJ?With Canada’s recreational MJ industy recently being legalized, cannabis stocks are captivating the markets. And if you’ve been following along, you would have already seen that one particular MJ Stock could be making a new trend and we’ve got the details for you, here.Read The Full Report

The Marijuana Market in Uruguay Runs Into Supply Problem

The legal cannabis market around the world has seen a large boom over the course of the past five years. One of the earlier international markets to come into the space was Uruguay, legalizing the use of cannabis as of five years ago in 2013. The law in Uruguay states that consumers can buy up to 1.5 ounces of the substances or 40 grams, but purchasing cannabis domestically has become a challenge in itself.Read The Full Article Here

Continue reading
  9 Hits
  0 Comments
9 Hits
0 Comments

The Marijuana Industry Continues To Grow At a Rapid Pace

The cannabis market has been growing at quite a substantial rate over the course of the past five or so years. With a large amount of support from the public, it seems as though the marijuana industry is just now getting started.

A new report shows that the U.S. marijuana industry could potentially reach as much as $22 billion in the next four or so years by 2022. This number is quite large considering where cannabis currently is at around $6 billion. The tripling of value in the industry is something that has not before been seen and seems to be the main drawing factor for investors to continue coming into the space. Not a lot of industry can produce this kind of growth, but marijuana continues to highlight the perception of the drug and its usefulness as the main reason for this massive growth.

The marijuana industry seems like it has no place to go but up according to many studies done recently. Currently, in the U.S., there are as many as 30 states with some sort of legal measures put in place for use of cannabis by the public. Nine of these states including the District of Columbia allow the use of recreational cannabis for those who are over twenty-one years old. The newness of this industry can only be shown in the fact that many of these states have only recently put this new legislation in place such as Arkansas, Florida, North Dakota and others. With the large and growing California market only going into effect earlier this year, it seems as though this is just the beginning of the massive growing market in the U.S. and beyond. Many states have also been working to cement new legislation for the industry to allow the use of recreational cannabis and not just medicinal use, which could help to boost the revenue of the greater market overall.

One figure shows that “Colorado’s recreational marijuana market opened in 2014. Total marijuana sales that year (including medical and recreational marijuana) were nearly $684 million. Based on year-to-date revenue figures in Colorado, the state’s total marijuana sales in 2018 will probably be around $1.6 billion. That’s 134% growth in five years.” When looking at numbers like this, it is easy to see how the growth of the industry could continue to meet these high expectations in the coming years.

One stock that has continued to shock investors without even having a direct tie to the physical cannabis plant is the company Scotts-Miracle Gro (NYSE:SMG). The company has presented a new way to invest in the cannabis market and has helped to build the idea of ancillary industries that so many investors have been flocking to. Scotts traditionally is a company that offers solutions for growing plants, but as they realized the massive nature of the cannabis market, the company has been specifically producing new products to help meet the growing demand of the cannabis industry, and has marketed these products as such. Scott also recently acquired the company known as Sunlight Supply, which works by distributing hydroponic products to the U.S.

Continue reading
  8 Hits
  0 Comments
8 Hits
0 Comments

Why States Should be In Charge of Their Marijuana Industries

The marijuana industry across the U.S. has been in quite a topsy-turvy state for some time now as the ongoing battle between state and federal regulators has made the market difficult to dissect from a legal perspective. A new bill coming to the federal government may help solve this issue of power dynamic between what the states deserve and what the national government would like to see.

There are currently nine states in the U.S. that allow the use of adult-use recreational cannabis. These states have worked to grow quite sizable markets on growing, distribution and the individual retailers who sell the plants to the public. This means that anyone over the age of 21 can purchase marijuana in its varying forms throughout these states. This has been a large paradigm shift to the way that marijuana has been dealt with in the U.S. up until the past five to ten years. The recreational markets in these states are in a direct defiance to the law of the federal government. The U.S. government states that cannabis is currently a Schedule I narcotic. This means that from their perspective, cannabis has no potential for use in a medicinal setting as well as having a high possibility of addition. Both of these statements have been refuted many times by scientific journals and doctors alike around the world. The scheduling of the substance mostly refers to the paranoia surrounding the substance after a series of propaganda was released back in the early 20th century. It very obviously appears that the legislation needs to change, and this is precisely why the federal government has been hesitant to interfere fully with these legal markets.

A new bill has come out and could likely be signed into law in the coming weeks known as the Marijuana STATES act. The bill would effectively amend the substances scheduling on the Controlled Substances Act, and allow states the right to control their own internal marijuana industries. According to one report “ legal weed has flourished only because federal law hasn’t been enforced. The medical-marijuana business, still small, been protected for years by a rider to appropriations bills that bars federal money from funding their prosecution.”

The Obama administration was the first to offer the states some sort of protection under what is known as the “Cole Memo.” The Cole Memo meant that federal prosecutors had to take cannabis off of their priority in terms of prosecution, and thus states could act accordingly. The main opponent who worked to rescind this bill in the early parts of this year has been Attorney General Jeff Sessions. Sessions has been the primary reason that no new laws have been put into place.

The new STATES Act has been pushed forward by several individuals in government such as Senator Cory Gardner and Elizabeth Warren. The new bill aims at changing the current state of cannabis, and hopes to change the legislation that for too long, has not reflected at all the view of the public on cannabis. The market on cannabis in the U.S. and its legal status is still very new, which means that these small steps are all working in conjunction to help produce a better way for the country to deal with the use of legal cannabis nationwide. The hopes are high that these steps will all take the industry in the right direction, allowing the market to function as it should, and giving better access to cannabis for those who wish to use it and those who need it.

Continue reading
  5 Hits
  0 Comments
5 Hits
0 Comments

Choom™ (CHOOF) Announces Closing of Specialty Medijuana Products

Choom Announces Closing of Specialty Medijuana Products

Choom (CSE: CHOO; OTCQB: CHOOF) (the “Company” or “Choom“), an emerging fully-integrated cannabis company, is pleased to announce that today it is closing its acquisition (the “Transaction“) of Specialty Medijuana Products Inc. (“SMP“) pursuant to an amended and restated amalgamation agreement among Choom, Arbutus Brands Inc. and International Tungsten Inc. The Company announced the definitive agreement to effect the Transaction in a news release on March 19, 2018 .

“We are excited to add SMP to the Choom group of companies under our Arbutus Brands subsidiary,” states Chris Bogart , President and CEO for Choom.  “Arbutus Brands will add value to the entire Choom supply chain, from seed to sale. The synergies among our Choom companies will make for an extremely bright and exciting future as we approach the legalization of the recreational cannabis market in Canada .”

Transaction Highlights

The benefits of the Transaction for Choom include that it will:

Enable Choom to acquire SMP, which has submitted its AOR evidence package to Health Canada and expects to receive its cultivation license at any time;Create significant synergies in operational infrastructure and expertise across multiple disciplines to drive strong growth potential;Significantly improve and advance operational scale and production capacity; andStrengthen and accelerate Choom’s strategic direction as a fully-integrated cannabis company, representing a premiere lifestyle brand in Canada .

Specialty Medijuana Products Inc.

Continue reading
  9 Hits
  0 Comments
9 Hits
0 Comments

Aphria Inc. (APHQF) Appoints Former Southern Glazer’s Executive Joel Toguri as Vice President of Sales

Aphria Appoints Former Southern Glazer’s Executive Joel Toguri as Vice President of Sales

Aphria Inc. (“Aphria” or the “Company“) (TSX: APH and US OTC: APHQF) today announced the appointment of Joel Toguri as Vice President of Sales effective on June 18, 2018 . Mr. Toguri joins the Company from Southern Glazer’s of Canada (“Southern Glazer’s“), where he was Vice President of Sales and Operations since 2013.

“We’re thrilled to bring Joel’s incredible talent and considerable experience to Aphria,” said Jakob Ripshtein, Chief Commercial Officer at Aphria. “Over many years, Joel has developed a proven track record of driving sales, generating growth and delivering results. His experience in building Southern Glazer’s in Canada and his deep familiarity with our exclusive sales distribution partner will help to ensure Aphria’s brands and products are successfully represented by cannabis retailers throughout the country.”

Mr. Toguri brings more than 20 years’ experience in the Canadian beverage alcohol industry. As Southern Glazer’s first employee in Canada , he was charged with establishing the company’s footprint throughout the country. He led a national sales team of more than 90 people and drove the company to become the #3 Agent/Broker in Canada in just three years. Prior to Southern Glazer’s, Mr. Toguri held leadership roles at MolsonCoors, Maxxium Wine & Spirits, and Beam Global Spirits & Wine.

“Aphria is amazingly well-positioned to capitalize on the opportunities in the adult-use market from coast to coast, right out of the gate,” said Mr. Toguri. “I am excited to be joining a true leader in the industry, and I look forward to continuing my close relationship with the dedicated team from Great North Distributors to drive the long-term success of Aphria and the Company’s portfolio of brands following legalization.”

We Have a Good Thing Growing.

Continue reading
  8 Hits
  0 Comments
8 Hits
0 Comments

The Green Organic Dutchman Holdings Ltd. (TGOD.TO) (TGODF) Adds Additional 14,000 kg by Entering Jamaica Through Strategic Partnership

The Green Organic Dutchman Adds Additional 14,000 kg by Entering Jamaica Through Strategic Partnership With Epican Medicinals Ltd.

The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TGOD.TO) (TGODF) is pleased to announce it has entered into a strategic partnership with Epican Medicinals Ltd. This partnership will add an additional 14,000 kgs, taking TGOD’s total organic funded capacity to 130,000 kgs. Epican is a vertically integrated Jamaican cannabis company with cultivation, extraction, manufacturing and retail distribution licenses. This strategic partnership introduces TGOD’s premier organic cannabis brand to the international medical market.

“This represents the first of many strategic partnerships TGOD intends to execute in the coming months,” said Robert Anderson, CEO. “Our value-added approach taken in this investment will set an international M&A framework for capital investment, transfer of knowledge, and sector expertise. We will continue to evaluate international opportunities that will assist us in executing our business plan to become the world’s largest organic cannabis brand,” continued Anderson.

Epican produces high quality cannabis at its primary Blue Mountain cultivation site and has partnered with TGOD to construct a second 125,000 sq. ft. GMP compliant facility. Upon receiving the second site license, both facilities will cultivate high premium organic strains for the Jamaican and international markets. The Company will be working with Eco-Cert to achieve organic certification in Jamaica.

Epican’s extraction laboratory has been designed, licensed and built to GMP standards, establishing the company as a leader in sustainability with Jamaica’s Cannabis Licensing Authority (“CLA”). The company intends to sell a wide range of products such as dried flower, oils, pre-rolled joints, vapes, tinctures, among others. Epican’s initial offering of 11 scientifically formulated products will allow the company to service medical cannabis patients through its network of retail dispensaries (“Herb Houses”).

Jamaican dispensaries, known as Herb Houses, are crucial to the distribution of cannabis in Jamaica. Epican, with its first mover advantage, is opening its flagship dispensary in July 2018 located in Kingston, Jamaica. This will represent the first of many Herb Houses, with several more to be completed by the end of 2018 including locations along Jamaica’s northern coast. These locations will serve the medical needs of Jamaica’s 3 million residents and approximate 3.5 million visitors each year.

Continue reading
  9 Hits
  0 Comments
9 Hits
0 Comments

Marijuana Stocks Newsletter – Thursday June 14, 2018

Good Morning & Happy Thursday! – 6/14/2018!

What’s The Next Big Wave For MJ?With Canada’s recreational MJ industy recently being legalized, cannabis stocks are captivating the markets. And if you’ve been following along, you would have already seen that one particular MJ Stock could be making a new trend and we’ve got the details for you, here.Read The Full Report

What Has Been Impacting Marijuana Stocks In 2018?The cannabis market throughout the world has seen a large amount of success in terms of implementation and legal measures, but many changes have yet to hit the market that are currently in development.Read The Full Article Here

How Is Marijuana Being Used As A Pain Management Drug

There is no doubt that there is a large amount of research showing the various positives surrounding the cannabis plant. With a large amount of medical studies currently being conducted, marijuana has been praised from a high level for its potential in everything from pain management to cancer treatment. Many users have been turning to cannabis to help deal with large amounts of pain, and the results are quite shocking.Read The Full Article Here

Continue reading
  8 Hits
  0 Comments
8 Hits
0 Comments

PharmaCyte Biotech, Inc. (PMCB) Successfully Completes Another FDA Required Study

PharmaCyte Biotech Successfully Completes Another FDA Required Study Necessary for Submitting Investigational New Drug Application

PharmaCyte Biotech, Inc. (PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has successfully completed the comprehensive characterization of its proprietary cell clone known as 22P1G.

The 22P1G cells constitute the cells in the Master Cell Bank (MCB) that were prepared and tested by PharmaCyte’s contractor, Eurofins Lancaster Laboratories. The cells from the MCB will serve as the active pharmaceutical ingredient (API) in the company’s Cell-in-a Box® capsules that will be used (together with low doses of the cancer prodrug ifosfamide) for the treatment of locally advanced, non-metastatic, inoperable pancreatic cancer (LAPC) in its planned clinical trial.

The comprehensive characterization studies include long-term stability of the cells, and stability of the potency of the cells as a therapeutic. All studies performed are required by the U.S. Food and Drug Administration (FDA).

PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner, elaborated on the significance of the studies saying, “PharmaCyte is complying with all of the FDA guidelines and recommendations for all cell tests and other recent studies with the 22P1G cells. Successful completion of these studies was a pre-requisite for the approval by the FDA for us to conduct a clinical trial in patients with LAPC. Our treatment is primarily dependent upon genetically engineered live-human cells that produce a particularly potent cytochrome P450 enzyme that can activate the chemotherapy prodrug ifosfamide (clone 22P1G cells).

Continue reading
  7 Hits
  0 Comments
7 Hits
0 Comments